Dimensional Fund Advisors LP Stoke Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 265,010 shares of STOK stock, worth $3.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
265,010
Previous 191,360 38.49%
Holding current value
$3.1 Million
Previous $2.59 Million 25.96%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$12.24 - $15.92 $901,476 - $1.17 Million
73,650 Added 38.49%
265,010 $3.26 Million
Q2 2024

Aug 09, 2024
SELL
$11.03 - $17.52 $313,307 - $497,655
-28,405 Reduced 12.93%
191,360 $2.59 Million
Q1 2024

May 10, 2024
BUY
$4.12 - $14.17 $18,420 - $63,354
4,471 Added 2.08%
219,765 $2.97 Million
Q4 2023

Feb 07, 2024
SELL
$3.37 - $5.4 $145,341 - $232,891
-43,128 Reduced 16.69%
215,294 $1.13 Million
Q3 2023

Nov 09, 2023
SELL
$3.78 - $11.99 $308,912 - $979,858
-81,723 Reduced 24.03%
258,422 $1.02 Million
Q2 2023

Aug 09, 2023
BUY
$7.93 - $13.82 $368,848 - $642,809
46,513 Added 15.84%
340,145 $3.62 Million
Q1 2023

May 12, 2023
BUY
$7.65 - $10.38 $12,431 - $16,867
1,625 Added 0.56%
293,632 $2.45 Million
Q4 2022

Feb 09, 2023
SELL
$7.07 - $15.69 $332,212 - $737,257
-46,989 Reduced 13.86%
292,007 $2.7 Million
Q3 2022

Nov 10, 2022
BUY
$12.56 - $22.53 $929,126 - $1.67 Million
73,975 Added 27.91%
338,996 $4.35 Million
Q2 2022

Aug 12, 2022
BUY
$10.36 - $23.93 $1.17 Million - $2.71 Million
113,361 Added 74.75%
265,021 $3.5 Million
Q1 2022

May 13, 2022
BUY
$17.19 - $26.1 $1.37 Million - $2.08 Million
79,518 Added 110.22%
151,660 $3.19 Million
Q4 2021

Feb 09, 2022
BUY
$18.11 - $30.72 $496,630 - $842,434
27,423 Added 61.32%
72,142 $1.73 Million
Q3 2021

Nov 12, 2021
SELL
$23.65 - $34.44 $1.43 Million - $2.09 Million
-60,664 Reduced 57.57%
44,719 $1.14 Million
Q2 2021

Aug 12, 2021
SELL
$30.53 - $41.09 $105,023 - $141,349
-3,440 Reduced 3.16%
105,383 $3.55 Million
Q1 2021

May 14, 2021
BUY
$36.08 - $69.81 $2.49 Million - $4.82 Million
69,010 Added 173.34%
108,823 $4.22 Million
Q4 2020

Feb 25, 2021
BUY
$33.62 - $61.93 $1.34 Million - $2.47 Million
39,813 New
39,813 $2.47 Million

Others Institutions Holding STOK

# of Institutions
124
Shares Held
57.6M
Call Options Held
9.3K
Put Options Held
35.2K
View Full List

About Stoke Therapeutics, Inc.

STOK Quotes by TradingView
  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $460M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email